Home Finerenone Cuts Deaths in Mid-Stage Trial
 

Keywords :   


Finerenone Cuts Deaths in Mid-Stage Trial

2015-09-01 05:16:57| Chemicals - Topix.net

Promising data from an exploratory phase IIb trial of finerenone , an oral, nonsteroidal mineralocorticoid receptor antagonist , have been presented at the European Society of Cardiology Congress 2015 in London. The ARTS-HF study investigated the effects of different dosages of finerenone compared with eplerenone in patients with worsening chronic heart failure with a reduced ejection fraction as well as type-2 diabetes mellitus and/or chronic kidney disease.

Tags: trial cuts deaths

Category:Chemicals

Latest from this category

All news

12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »